P Gilsanz1, A Winning1, K C Koenen2, A L Roberts1, J A Sumner2, Q Chen3, M M Glymour4, E B Rimm2, L D Kubzansky1. 1. Department of Social and Behavioral Sciences,Harvard T.H. Chan School of Public Health,Boston, MA,USA. 2. Department of Epidemiology,Harvard T.H. Chan School of Public Health,Boston,MA,USA. 3. Department of Biostatistics,Mailman School of Public Health, Columbia University,New York,NY,USA. 4. Department of Epidemiology and Biostatistics,University of California San Francisco School of Medicine,San Francisco, CA,USA.
Abstract
BACKGROUND: Prior studies suggest that post-traumatic stress disorder (PTSD) is associated with elevated cardiovascular disease (CVD) risk, but effects of duration and remission of PTSD symptoms have rarely been evaluated. METHOD: We examined the association of time-updated PTSD symptom severity, remission and duration with incident CVD risk (552 confirmed myocardial infarctions or strokes) over 20 years in 49 859 women in the Nurses' Health Study II. Among women who reported trauma on the Brief Trauma Questionnaire, PTSD symptoms, assessed by a screener, were classified by symptom severity and chronicity: (a) no symptoms, (b) 1-3 ongoing, (c) 4-5 ongoing, (d) 6-7 ongoing, (e) 1-3 remitted, (f) 4-7 remitted symptoms. Inverse probability weighting was used to estimate marginal structural logistic regression models, adjusting for time-varying and time-invariant confounders. RESULTS: Compared with women with no trauma exposure, women with trauma/no PTSD [odds ratio (OR) 1.30, 95% confidence interval (CI) 1.03-1.65] and women with trauma/6-7 symptoms (OR 1.69, 95% CI 1.08-2.63) had elevated risk of CVD; women with remitted symptoms did not have elevated CVD risk. Among women exposed to trauma, every 5 additional years of PTSD symptomology was associated with 9% higher CVD incidence compared with women with trauma/no PTSD. CONCLUSIONS: The findings suggest that alleviating PTSD symptoms shortly after onset may attenuate CVD risk.
BACKGROUND: Prior studies suggest that post-traumatic stress disorder (PTSD) is associated with elevated cardiovascular disease (CVD) risk, but effects of duration and remission of PTSD symptoms have rarely been evaluated. METHOD: We examined the association of time-updated PTSD symptom severity, remission and duration with incident CVD risk (552 confirmed myocardial infarctions or strokes) over 20 years in 49 859 women in the Nurses' Health Study II. Among women who reported trauma on the Brief Trauma Questionnaire, PTSD symptoms, assessed by a screener, were classified by symptom severity and chronicity: (a) no symptoms, (b) 1-3 ongoing, (c) 4-5 ongoing, (d) 6-7 ongoing, (e) 1-3 remitted, (f) 4-7 remitted symptoms. Inverse probability weighting was used to estimate marginal structural logistic regression models, adjusting for time-varying and time-invariant confounders. RESULTS: Compared with women with no trauma exposure, women with trauma/no PTSD [odds ratio (OR) 1.30, 95% confidence interval (CI) 1.03-1.65] and women with trauma/6-7 symptoms (OR 1.69, 95% CI 1.08-2.63) had elevated risk of CVD; women with remitted symptoms did not have elevated CVD risk. Among women exposed to trauma, every 5 additional years of PTSD symptomology was associated with 9% higher CVD incidence compared with women with trauma/no PTSD. CONCLUSIONS: The findings suggest that alleviating PTSD symptoms shortly after onset may attenuate CVD risk.
Authors: Steven S Fu; Miles McFall; Andrew J Saxon; Jean C Beckham; Timothy P Carmody; Dewleen G Baker; Anne M Joseph Journal: Nicotine Tob Res Date: 2007-11 Impact factor: 4.244
Authors: Stephanie E Chiuve; Teresa T Fung; Eric B Rimm; Frank B Hu; Marjorie L McCullough; Molin Wang; Meir J Stampfer; Walter C Willett Journal: J Nutr Date: 2012-04-18 Impact factor: 4.798
Authors: Laura D Kubzansky; Shelley S Tworoger; Andrea L Roberts; Tianyi Huang; Karestan C Koenen; Yongjoo Kim Journal: Cancer Res Date: 2019-09-05 Impact factor: 12.701
Authors: Jeffrey F Scherrer; Joanne Salas; F David Schneider; Matthew J Friedman; Carissa van den Berk-Clark; Kathleen M Chard; Sonya B Norman; Patrick J Lustman; Peter Tuerk; Paula P Schnurr; Beth E Cohen Journal: J Psychosom Res Date: 2020-05-04 Impact factor: 3.006
Authors: Kaela Connors; Mario H Flores-Torres; Dalia Stern; Unnur Valdimarsdóttir; Jennifer R Rider; Ruy Lopez-Ridaura; Clemens Kirschbaum; Carlos Cantú-Brito; Andrés Catzin-Kuhlmann; Beatriz L Rodriguez; Catalina Pérez Correa; Martín Lajous Journal: Am J Public Health Date: 2020-01 Impact factor: 9.308
Authors: D A C Oprel; C M Hoeboer; M Schoorl; R A De Kleine; I G Wigard; M Cloitre; A Van Minnen; W Van der Does Journal: BMC Psychiatry Date: 2018-12-12 Impact factor: 3.630
Authors: Carsten Spitzer; Johanna Klinger-König; Stefan Frenzel; Ulf Schminke; Henry Völzke; Laura Lübke; Hans Jörgen Grabe Journal: Eur J Psychotraumatol Date: 2020-10-14